DCM
ARIA

Driehaus Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Driehaus Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-44,242
Closed -$327K – 680
2016
Q2 		$327K Buy
+44,242
New +$332K 0.01% 470
2014
Q2 		– Sell
-29,600
Closed -$239K – 680
2014
Q1 		$239K Buy
29,600
+15,600
+111% +$122K 0.01% 476
2013
Q4 		$95K Buy
+14,000
New +$75.6K ﹤0.01% 457

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Driehaus Capital Management's ARIA Position: Q3 2016 in Review

Driehaus Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 44,242 shares — an estimated $327K sold.

Driehaus Capital Management first reported a position in ARIA in Q4 2013 and held it in 3 quarters. The position peaked at $327K in Q2 2016. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Driehaus Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Driehaus Capital Management sold 44,242 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $327K.
  • Driehaus Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 3 quarters.
  • Driehaus Capital Management's Ariad Pharmaceuticals Inc position peaked at $327K in Q2 2016.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Driehaus Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.